Portaero Quietly Gets Funding For COPD Treatment
Menlo Park-based Portaero, a stealth medical devices firm, has quietly raised a round of funding from Versant Ventures, silicontap has learned. The funding has not been announced. According to Versant Ventures, Portaero is developing a device for the treatment of COPD (Chronic obstructive pulmonary disease). No details of the investment have been released.
posted on Thursday, November 8, 2007 (Link to more information)
Related companies:
Portaero
Related stories:
> Propeller Health Acquired For $225M By ResMed
> Pearl Therapeutics Acquired For $1.15 Billion
> Sendori Quietly Gets Investment
> EBR Systems Raises $50M For Wireless Heart Failure Treatment System
> Breathe Technologies Takes In $15M
silicontap.com Home